MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced results from two prespecified analyses from the Phase 3 CLEAR (Cholesterol Lowering via Bempedoic Acid, an ...
CEDHARS is pleased to announce the recipients of its spring 2023 pilot grant funding opportunity, “Secondary Data Analysis to Advance Health or Rehabilitation Outcomes Research in People with ...